Skip to content

Anti-HIV-1 Antibody Titration (Serum/Plasma)

Published: August 9, 2026Updated: August 16, 2026

This test measures the amount of antibodies your body produces in response to the HIV virus. It helps determine if you have been exposed to HIV and whether your immune system is responding.

Quick summary

["Assesses HIV exposure and immune response through antibody levels over time."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
15471-6
Short code
EIV A2 Ab Titr Ser HAI
Synonyms
EIV A2 Ab Titr Ser HAI
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
hai
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What This Test Measures

The test detects HIV-specific antibodies in your blood or plasma. Antibodies are proteins your immune system makes to fight infections. Over time, your body may produce more or less of these antibodies depending on how your immune system reacts to HIV. Titration helps track changes in antibody levels, which can inform further medical evaluation.

Why It’s Done

Your healthcare provider may order this test if you have symptoms of HIV infection, have been exposed to HIV, or are part of a study to monitor immune response. It’s also used in some cases to confirm or rule out HIV after initial screening.

Sample Collection and Preparation

A blood sample is drawn from a vein in your arm. The blood is then processed to separate serum or plasma, which is tested for HIV antibodies. This process ensures accurate measurement of antibody levels.

What to Expect Before the Test

There are no special preparations needed. You may have a small bandage on the site where the blood was drawn, but otherwise, you can resume normal activities immediately.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

HIV Antibody Test (Titration)

Frequently asked questions

If antibody levels are detected, it suggests past or current exposure to HIV. Higher or fluctuating levels may indicate an active immune response, while lower levels could mean the body is less reactive. This information helps guide treatment decisions, such as starting antiretroviral therapy (ART) or monitoring disease progression.
This test is not a direct measure of HIV virus levels (viral load) but supports broader assessment of HIV status and immune health.
How does antibody titration differ from a standard HIV antibody test?
A standard HIV antibody test (like an ELISA) provides a binary result (positive or negative). Titration, however, measures the exact amount of antibodies, which can help determine the strength of your immune response and whether further testing is needed for confirmation.
Can this test be used to diagnose HIV immediately?
No, this test is typically used after initial screening to confirm or refine results. It’s not a first-line diagnostic tool but supports detailed evaluation of immune response to HIV.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy